@ABsteward There aren’t any Colistin “susceptible” breakpoints for Acinetobacter per CLSI. I think the main issue with colistin is achieving adequate concentrations in areas outside of the urinary tract. This is a good summary of the PK/PD data https://t.c
Esp since it has a narrow therapeutic window and the 2019 guidelines suggest a Css of 2 mg/L https://t.co/RlVUAvpgmy https://t.co/3nrLiedhXG
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infect Diseases Society of America IDSA https://t.co/NziUy7eHeZ
RT @khalid_eljaaly2: 🔥 وأخيرا نزلت توصيات خاصة بالكولستين طال انتظارها. أغلب من جهزها صيادلة أمراض معدية. انشروها لتعم الفائدة: https://t.c…
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College oy for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP) https://t.
RT @PharmacoJournal: This Editor’s Choice manuscript shows how established drugs with decades of experience should not be overlooked for th…
RT @PharmacoJournal: This Editor’s Choice manuscript shows how established drugs with decades of experience should not be overlooked for th…
RT @PharmacoJournal: This Editor’s Choice manuscript shows how established drugs with decades of experience should not be overlooked for th…
This Editor’s Choice manuscript shows how established drugs with decades of experience should not be overlooked for their potential contribution to current pharmacotherapeutic challenges. https://t.co/yJQYUgFgTi Downloaded >82K times! @BrianTsuji @jpogu
RT @khalid_eljaaly2: 🔥 وأخيرا نزلت توصيات خاصة بالكولستين طال انتظارها. أغلب من جهزها صيادلة أمراض معدية. انشروها لتعم الفائدة: https://t.c…
International Consensus Guidelines for the Optimal Use of the Polymyxins https://t.co/HzSExVTvRE
Fascinating talk by Prof Roger Nation on his PK/PD work on polymyxins at #SHPA #PSA collaborative research day. And now international consensus guidelines published! #colistin #AMR @the_shpa @PSA_National https://t.co/dlRsV756fC https://t.co/kFzZ1Fy80t
RT @khalid_eljaaly2: 🔥 وأخيرا نزلت توصيات خاصة بالكولستين طال انتظارها. أغلب من جهزها صيادلة أمراض معدية. انشروها لتعم الفائدة: https://t.c…
RT @PharmacoJournal: Retro drug, contemporary standards. Consensus guidelines for the optimal use of polymyxins in the @ACCP 40th Anniversa…
RT @PharmacoJournal: Retro drug, contemporary standards. Consensus guidelines for the optimal use of polymyxins in the @ACCP 40th Anniversa…
Like bellbottoms?? 😂
RT @PharmacoJournal: Retro drug, contemporary standards. Consensus guidelines for the optimal use of polymyxins in the @ACCP 40th Anniversa…
Retro drug, contemporary standards. Consensus guidelines for the optimal use of polymyxins in the @ACCP 40th Anniversary Issue https://t.co/yJQYUgFgTi @ESCMID @IDSAInfo @ISAP__org @SCCM @SIDPharm @BrianTsuji @jpogue1 @Keith_S_Kaye @Wiley_Health https://t.c
RT @khalid_eljaaly2: 🔥 وأخيرا نزلت توصيات خاصة بالكولستين طال انتظارها. أغلب من جهزها صيادلة أمراض معدية. انشروها لتعم الفائدة: https://t.c…
RT @salam_rasha: Important to remember, read, and review #Polymixin use Guidelines https://t.co/T2Se7GeHPi from @ACCP, @IDSAInfo, @ESCM…
Important to remember, read, and review #Polymixin use Guidelines https://t.co/T2Se7GeHPi from @ACCP, @IDSAInfo, @ESCMID, @SIDPharm, @ISAP_org, @SCCM, @accpinfdprn #AntibioticResistance #AntibioticAwarenessWeek #AntibioticGuardian https://t.co/DHRh
RT @Ph_A7med80: @Mohhor4 @ph_tws القايد الجديد تبع الكوليستين يعتمد على حساب الكرياتينين كليرنس وليس الحسبة القديمة https://t.co/a4mOhsYavq
@Mohhor4 @ph_tws القايد الجديد تبع الكوليستين يعتمد على حساب الكرياتينين كليرنس وليس الحسبة القديمة https://t.co/a4mOhsYavq
RT @Wiley_Health: Retro drug, contemporary standards. Consensus guidelines for the optimal use of polymyxins in @PharmacoJournal: @ACCP 40t…
RT @Wiley_Health: Retro drug, contemporary standards. Consensus guidelines for the optimal use of polymyxins in @PharmacoJournal: @ACCP 40t…
Retro drug, contemporary standards. Consensus guidelines for the optimal use of polymyxins in @PharmacoJournal: @ACCP 40th Anniversary Issue https://t.co/3UcHNaTzzZ @ESCMID @IDSAInfo @ISAP__org @SCCM @SIDPharm @BrianTsuji @jpogue1 @Keith_S_Kaye https://t.
RT @khalid_eljaaly2: 🔥 وأخيرا نزلت توصيات خاصة بالكولستين طال انتظارها. أغلب من جهزها صيادلة أمراض معدية. انشروها لتعم الفائدة: https://t.c…
RT @khalid_eljaaly2: 🔥 وأخيرا نزلت توصيات خاصة بالكولستين طال انتظارها. أغلب من جهزها صيادلة أمراض معدية. انشروها لتعم الفائدة: https://t.c…
RT @khalid_eljaaly2: 🔥 وأخيرا نزلت توصيات خاصة بالكولستين طال انتظارها. أغلب من جهزها صيادلة أمراض معدية. انشروها لتعم الفائدة: https://t.c…
RT @khalid_eljaaly2: 🔥 وأخيرا نزلت توصيات خاصة بالكولستين طال انتظارها. أغلب من جهزها صيادلة أمراض معدية. انشروها لتعم الفائدة: https://t.c…
RT @khalid_eljaaly2: 🔥 وأخيرا نزلت توصيات خاصة بالكولستين طال انتظارها. أغلب من جهزها صيادلة أمراض معدية. انشروها لتعم الفائدة: https://t.c…
RT @khalid_eljaaly2: 🔥 وأخيرا نزلت توصيات خاصة بالكولستين طال انتظارها. أغلب من جهزها صيادلة أمراض معدية. انشروها لتعم الفائدة: https://t.c…
RT @khalid_eljaaly2: 🔥 وأخيرا نزلت توصيات خاصة بالكولستين طال انتظارها. أغلب من جهزها صيادلة أمراض معدية. انشروها لتعم الفائدة: https://t.c…
RT @khalid_eljaaly2: 🔥 وأخيرا نزلت توصيات خاصة بالكولستين طال انتظارها. أغلب من جهزها صيادلة أمراض معدية. انشروها لتعم الفائدة: https://t.c…
(лечу пациента полимиксином B первый раз в жизни)) International consensus guidelines for the optimal use of the polymyxins: endorsed by the ACCP, ESCMID, IDSA, ISAP, SCCM, and SIDP. Pharmacotherapy 2019;39(1):10–39. https://t.co/Xo67QxNOyQ
@olivaresabara
@JoshOsowicki @davidantibiotic @Cortes_Penfield @PaulSaxMD @mmPharmD @gabhaeusler @FungalDoc @CarlosdelRio7 @TrubianoJason @padstamundo This is an excellent @PharmacoJournal @BrianTsuji @jpogue1 @Keith_S_Kaye International Consensus Guidelines for the Op
RT @MicrobLog_me_uk: International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by @IDSAInfo @ACCP @ESCMID http…
RT @perfectmed_ec: International Consensus Guidelines for the Optimal Use of the Polymyxins https://t.co/uIuVIPYSTx https://t.co/EpRneYA1Wi
RT @perfectmed_ec: International Consensus Guidelines for the Optimal Use of the Polymyxins https://t.co/uIuVIPYSTx https://t.co/EpRneYA1Wi
International Consensus Guidelines for the Optimal Use of the Polymyxins https://t.co/uIuVIPYSTx https://t.co/EpRneYA1Wi
RT @EARL_Med_Tw: コリスチンおよびポリミキンBの適正使用に関するコンセンサスガイドライン：ACCP/ESCMID/IDSA/ISAP/SCCM/SIDP（Pharmacotherapy 2019;39:10-39） https://t.co/Jy6zlLB80A
コリスチンおよびポリミキンBの適正使用に関するコンセンサスガイドライン：ACCP/ESCMID/IDSA/ISAP/SCCM/SIDP（Pharmacotherapy 2019;39:10-39） https://t.co/Jy6zlLB80A
RT @MicrobLog_me_uk: International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by @IDSAInfo @ACCP @ESCMID http…
RT @MicrobLog_me_uk: International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by @IDSAInfo @ACCP @ESCMID http…
RT @MicrobLog_me_uk: International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by @IDSAInfo @ACCP @ESCMID http…
RT @MicrobLog_me_uk: International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by @IDSAInfo @ACCP @ESCMID http…
RT @MicrobLog_me_uk: International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by @IDSAInfo @ACCP @ESCMID http…
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by @IDSAInfo @ACCP @ESCMID https://t.co/lCti5kmorU
RT @FarmaciaHGUCS: La complejidad de las infecciones y la creciente aparición de resistencias hace necesaria la correcta optimización de tr…
RT @FarmaciaHGUCS: La complejidad de las infecciones y la creciente aparición de resistencias hace necesaria la correcta optimización de tr…
RT @FarmaciaHGUCS: La complejidad de las infecciones y la creciente aparición de resistencias hace necesaria la correcta optimización de tr…
RT @FarmaciaHGUCS: La complejidad de las infecciones y la creciente aparición de resistencias hace necesaria la correcta optimización de tr…
La complejidad de las infecciones y la creciente aparición de resistencias hace necesaria la correcta optimización de tratamiento con colistina. Nuevas guias de práctica clínica @FortanetMaria @Grupo_AFinf_SEF https://t.co/J4P4Jf2da8 https://t.co/wtlhJixzw
Really important: International Consensus Guidelines for the Optimal Use of the Polymyxins - Tsuji - 2019 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Wiley Online Library https://t.co/M91nR7pFWz
📘 В журнале «Pharmacotherapy» опубликованы международные консенсусные рекомендации по оптимальному применению полимиксинов. https://t.co/xJcF8gX29X
RT @SGarciaMunoz: International Consensus Guidelines for the Optimal Use of the Polymyxins https://t.co/jXPELU0mLy Dosis de mantenimiento…
RT @SGarciaMunoz: International Consensus Guidelines for the Optimal Use of the Polymyxins https://t.co/jXPELU0mLy Dosis de mantenimiento…
International Consensus Guidelines for the Optimal Use of the Polymyxins https://t.co/jXPELU0mLy Dosis de mantenimiento de Colistina según ClCr https://t.co/xfZxfGuYMo
RT @PharmacoJournal: Endorsed by: @ACCP @ESCMID @IDSAInfo @ISAP_org @SCCM and @SIDPharm https://t.co/QcXO6r4Iw7 @briantsuji @jpogue1 @Keit…
International Consensus Guidelines for the Optimal Use of the Polymyxins https://t.co/hECrQte8u0
RT @SIDPharm: NEW! First ever consensus recommendations for colistin & polymyxin B therapy: selection, dosing, PK/PD targets, monitoring, c…
RT @ABsteward: NEW 🔥🔥🔥Just published in @PharmacoJournal @BrianTsuji @jpogue1 @Keith_S_Kaye International Consensus Guidelines for the Op…
RT @ABsteward: NEW 🔥🔥🔥Just published in @PharmacoJournal @BrianTsuji @jpogue1 @Keith_S_Kaye International Consensus Guidelines for the Op…
RT @ABsteward: NEW 🔥🔥🔥Just published in @PharmacoJournal @BrianTsuji @jpogue1 @Keith_S_Kaye International Consensus Guidelines for the Op…
RT @ABsteward: NEW 🔥🔥🔥Just published in @PharmacoJournal @BrianTsuji @jpogue1 @Keith_S_Kaye International Consensus Guidelines for the Op…
RT @ABsteward: NEW 🔥🔥🔥Just published in @PharmacoJournal @BrianTsuji @jpogue1 @Keith_S_Kaye International Consensus Guidelines for the Op…
RT @ABsteward: NEW 🔥🔥🔥Just published in @PharmacoJournal @BrianTsuji @jpogue1 @Keith_S_Kaye International Consensus Guidelines for the Op…
RT @ABsteward: NEW 🔥🔥🔥Just published in @PharmacoJournal @BrianTsuji @jpogue1 @Keith_S_Kaye International Consensus Guidelines for the Op…
RT @ABsteward: NEW 🔥🔥🔥Just published in @PharmacoJournal @BrianTsuji @jpogue1 @Keith_S_Kaye International Consensus Guidelines for the Op…
RT @ABsteward: NEW 🔥🔥🔥Just published in @PharmacoJournal @BrianTsuji @jpogue1 @Keith_S_Kaye International Consensus Guidelines for the Op…
RT @ABsteward: NEW 🔥🔥🔥Just published in @PharmacoJournal @BrianTsuji @jpogue1 @Keith_S_Kaye International Consensus Guidelines for the Op…
RT @ABsteward: NEW 🔥🔥🔥Just published in @PharmacoJournal @BrianTsuji @jpogue1 @Keith_S_Kaye International Consensus Guidelines for the Op…
RT @SICUPharmD: @criticalbeansmd Also see new Polymyxin guidelines #CCC48 https://t.co/uLxFQfsaI9
International Consensus Guidelines for the Optimal Use of the Polymyxins. #FOAMed https://t.co/8Dywsvmetp
Uso apropiado colistina, vigilancia #nefrotoxicidad, #ajustedosis International Consensus Guidelines for the Optimal Use of the Polymyxins: https://t.co/nRjxlsdomE
RT @SICUPharmD: @criticalbeansmd Also see new Polymyxin guidelines #CCC48 https://t.co/uLxFQfsaI9
@criticalbeansmd Also see new Polymyxin guidelines #CCC48 https://t.co/uLxFQfsaI9
RT @sanfordguide: ID Update: Consensus guidelines for selection and dosing of colistin and polymyxin B as endorsed by @ACCP, @IDSAInfo, @SI…
Read later
RT @sanfordguide: ID Update: Consensus guidelines for selection and dosing of colistin and polymyxin B as endorsed by @ACCP, @IDSAInfo, @SI…
RT @Grupo_AFinf_SEF: New!!! Guía sobre polimixinas! (colistina) ➡️ PK/PD, dosing, adjustment, monitoring, combination therapy, IT, INH, tox…
RT @SIDPharm: NEW! First ever consensus recommendations for colistin & polymyxin B therapy: selection, dosing, PK/PD targets, monitoring, c…
RT @khalid_eljaaly2: 🔥 وأخيرا نزلت توصيات خاصة بالكولستين طال انتظارها. أغلب من جهزها صيادلة أمراض معدية. انشروها لتعم الفائدة: https://t.c…
RT @Freestylepharm1: Excited to dive into these soon! And all this time, I thought the correct answer to "what is the optimal way to use co…
RT @idpharmd: Great contribution to the literature👏👍👏 South Africa addresses One Health stewardship of colistin in @TheLancetInfDis also an…
RT @SIDPharm: NEW! First ever consensus recommendations for colistin & polymyxin B therapy: selection, dosing, PK/PD targets, monitoring, c…
Great contribution to the literature👏👍👏 South Africa addresses One Health stewardship of colistin in @TheLancetInfDis also an important topic @NSchellack @SouthAfricanASP @ABpreservation
RT @Grupo_AFinf_SEF: New!!! Guía sobre polimixinas! (colistina) ➡️ PK/PD, dosing, adjustment, monitoring, combination therapy, IT, INH, tox…
RT @Grupo_AFinf_SEF: New!!! Guía sobre polimixinas! (colistina) ➡️ PK/PD, dosing, adjustment, monitoring, combination therapy, IT, INH, tox…
RT @khalid_eljaaly2: 🔥 وأخيرا نزلت توصيات خاصة بالكولستين طال انتظارها. أغلب من جهزها صيادلة أمراض معدية. انشروها لتعم الفائدة: https://t.c…
RT @SIDPharm: NEW! First ever consensus recommendations for colistin & polymyxin B therapy: selection, dosing, PK/PD targets, monitoring, c…
RT @khalid_eljaaly2: 🔥 وأخيرا نزلت توصيات خاصة بالكولستين طال انتظارها. أغلب من جهزها صيادلة أمراض معدية. انشروها لتعم الفائدة: https://t.c…
RT @khalid_eljaaly2: 🔥 وأخيرا نزلت توصيات خاصة بالكولستين طال انتظارها. أغلب من جهزها صيادلة أمراض معدية. انشروها لتعم الفائدة: https://t.c…
RT @Saudi_Pharma_07: @xiiah9 #Colistin dosing https://t.co/AwDJBcMYE2
RT @Grupo_AFinf_SEF: New!!! Guía sobre polimixinas! (colistina) ➡️ PK/PD, dosing, adjustment, monitoring, combination therapy, IT, INH, tox…
RT @SIDPharm: NEW! First ever consensus recommendations for colistin & polymyxin B therapy: selection, dosing, PK/PD targets, monitoring, c…
RT @SIDPharm: NEW! First ever consensus recommendations for colistin & polymyxin B therapy: selection, dosing, PK/PD targets, monitoring, c…